myrtenol has been researched along with Reperfusion Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Huang, S; Tan, Z; Tian, Y; Wang, Z | 1 |
1 other study(ies) available for myrtenol and Reperfusion Injury
| Article | Year |
|---|---|
Myrtenol improves brain damage and promotes angiogenesis in rats with cerebral infarction by activating the ERK1/2 signalling pathway.
Topics: Angiogenesis Inducing Agents; Animals; Bicyclic Monoterpenes; Cerebral Infarction; Dose-Response Relationship, Drug; Male; MAP Kinase Signaling System; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |